Effect of Moxifloxacin(0.5mg) instillation in anterior chamber in Phacoemulsification surgery
- Conditions
- Health Condition 1: H259- Unspecified age-related cataract
- Registration Number
- CTRI/2020/06/025909
- Lead Sponsor
- Mohit kumar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Age group (40-80yr)
2. Senile cataract in patients associated with visual impairment.
3. Grade I - III cataract (grading will be done according to LOCS III classification
1.Patients with any ocular pathology other than cataracts such as retinal vascular disorders and ARMD and Diabetic retinopathy .
2. Ocular condition like glaucoma and uveitis .
3.Those with other media opacities corneal or vitreous .
4.Subjects with traumatic cataract, complicated cataract , grade 4 cataract
5.Patient with known case of diabetes mellitus
6.Patients who underwent previous intraocular surgery other than cataract.
7.Any intraoperative complication
1.Patients with any ocular pathology other than cataracts such as retinal vascular disorders and ARMD and Diabetic retinopathy .
2. Ocular condition like glaucoma and uveitis .
3.Those with other media opacities corneal or vitreous .
4.Subjects with traumatic cataract, complicated cataract , grade 4 cataract
5.Patient with known case of diabetes mellitus
6.Patients who underwent previous intraocular surgery other than cataract.
7.Any intraoperative complication
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to study the effect of intracameral moxifloxacin(0.5mg) on corneal endothelium in phacoemulsification surgeryTimepoint: Corneal endothelial cell count on day 1, 7 and 21 after surgery.
- Secondary Outcome Measures
Name Time Method TO COMPARE THE CHANGE IN MORPHOLOGY OF CORNEA â?? ENDOTHELIAL CELL COUNT , HEXAGONALITY, COEFICIENT OF VARIATION IN CELL AREA, CORNEAL THICKNESS DUE TO USE OF INTRACAMERAL MOXIFLOXACIN IN PHACOEMULSIFICATION SURGERY.Timepoint: day 1, 7 and 21 after surgery